comparative genomic hybridization
comparative genomic hybridization is a genetic therapy with 21 clinical trials. Currently 1 active trials ongoing. Historical success rate of 92.9%.
Success Metrics
Based on 13 completed trials
Phase Distribution
Phase Distribution
3
Early Stage
2
Mid Stage
1
Late Stage
Highest Phase Reached
Phase 3Trial Status & Enrollment
81.3%
13 of 16 finished
18.8%
3 ended early
1
trials recruiting
21
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Molecular Predictors of Cancer in Patients at High Risk of Lung Cancer
Combination Chemotherapy and Pralatrexate as First-Line Therapy in Treating Patients With Non-Hodgkin Lymphoma
DNA Analysis of Tumor Tissue From Patients With Acute Myeloid Leukemia
Oral HPV Infection in Young Men
Pharmacokinetics in Patients With Newly Diagnosed High-Grade Glioma Receiving Temozolomide and Radiation Therapy
Clinical Trials (21)
Molecular Predictors of Cancer in Patients at High Risk of Lung Cancer
Combination Chemotherapy and Pralatrexate as First-Line Therapy in Treating Patients With Non-Hodgkin Lymphoma
DNA Analysis of Tumor Tissue From Patients With Acute Myeloid Leukemia
Oral HPV Infection in Young Men
Pharmacokinetics in Patients With Newly Diagnosed High-Grade Glioma Receiving Temozolomide and Radiation Therapy
Identifying Biomarkers for Lung Cancer Using Tissue Samples From Patients With Lung Cancer and From Healthy Participants
Topical Sirolimus in Patients With Basal Cell Nevus Syndrome and in Healthy Participants
Diagnostic Study of Patients With Aggressive Non-Hodgkin's Lymphoma
Diagnostic Study to Predict the Risk of Developing Metastatic Cancer in Patients With Stage I or Stage II Melanoma
Biomarkers in Young Patients With Neuroblastoma
Research Study in Patients With Advanced Ovarian Epithelial Cancer
Biomarkers in Tissue Samples From Patients With Ewing Sarcoma
Gene Testing to Help in the Diagnosis and Treatment of Childhood Brain Tumors
Study of Blood and Tissue Samples From Patients Receiving Androgen Deprivation for Newly Diagnosed Prostate Cancer
Sunitinib Before and After Surgery in Treating Patients With Stage IV Kidney Cancer
Studying Genes for Barrett's Esophagus in Brothers and Sisters
Neoadjuvant Epirubicin, Cyclophosphamide, and Paclitaxel With or Without Gemcitabine in Treating Women Who Are Undergoing Surgery for Early Breast Cancer
S8814A Biomarkers in Predicting Outcome in Postmenopausal Women With Hormone Receptor-Positive, Node-Positive Breast Cancer Treated With Tamoxifen With or Without Cyclophosphamide, Doxorubicin, and Fluorouracil
Biomarkers in Stored Tumor Samples From Younger Patients With Liver Cancer
Lapatinib and Vinorelbine in Treating Patients With Advanced Solid Tumors
Drug Details
- Intervention Type
- GENETIC
- Total Trials
- 21